The continually expanding toolkit from Mohit Verma's laboratory at Purdue University now includes a portable, paper-based ...

CHENNAI: Mother Teresa Women’s University has developed an advanced PCR-based detection kit to ensure the authenticity of ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification.

The FDA imposed new restrictions on COVID-19 vaccines, limiting access to the updates shots to people who are at risk for ...

The Business Research Company’s Molecular Diagnostics For Sexually Transmitted Diseases Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 ...

Biofilm bacteria found in heart plaque may escape antibiotics and cause cardiac events, pointing to a hidden infectious risk.

Qiagen launches US FDA approved higher-throughput QIAstat-Dx Rise, a version of the QIAstat-Dx automated syndromic testing system: Germantown, Maryland Wednesday, September 3, 202 ...

The global molecular assay market was valued at USD 16.4 billion in 2024 and is projected to reach USD 24.6 billion by 2030, expected to grow at a CAGR of 7% during the forecast period, ...

Discover why Fulgent’s accelerating revenue and rising margins signal growth potential, with shares undervalued vs. cash.

HPV cfDNA is a highly effective tumor marker for monitoring disease progression and treatment response in HPV-positive cervical cancer, offering valuable insights for guiding clinical decisions in ...